Rothschedl, E. and Nachtnebel, A. (2015): Horizon Scanning in Oncology 23rd Prioritisation – 2nd quarter 2015. HSO: 23rd Prioritisation.
|PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader|
For the 23rd prioritisation (June 2015), 10 drugs were filtered out of 170 identified and were sent to prioritisation. Of these, 4 drugs were ranked as "highly relevant" by the expert panel, 5 as "relevant" and 1 as "not relevant". For "highly relevant" drugs, further information including, for example, abstracts of phase III studies and licensing status is contained in this document.
|Item Type:||DSD: Horizon Scanning in Oncology|
|Subjects:||WB Practice of medicine > WB 300-962 Therapeutics|
QZ Pathology > QZ 200-380 Neoplasms.Cysts
QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
|Series Name:||HSO: 23rd Prioritisation|
|Deposited on:||17 Aug 2015 12:10|
|Last Modified:||24 Aug 2017 15:23|
Repository Staff Only: item control page